Poster Abstracts222 UHR-Q-TOF Analysis Can AddressCommon Challenges in Targeted andUntargeted MetabolomicsA. Barsch 1 , G. Zurek 1 , D. Krug 2 , R. Müller 21Bruker Daltonics, Bremen, Germany; 2 Universitätdes Saarlandes, Saarbrücken, GermanyHere, we present an ESI-UHR-Q-TOF based analysis <strong>of</strong> myxobacterialsecondary metabolites, which permits to solve several challengesfrequently encountered in metabolite pr<strong>of</strong>iling studies. Myxobacteriaare promising producers <strong>of</strong> natural products exhibiting potentbiological activities, and several myxobacterial metabolites are currentlyunder investigation as potential leads for novel drugs. However, themyxobacteria are also a striking example for the divergence betweenthe genetic capacity for the production <strong>of</strong> secondary metabolitesand the number <strong>of</strong> compounds that could be characterised to date.Wildtype and mutant strains were analyzed concerning the productionpatterns <strong>of</strong> known metabolites and with regard to the discovery<strong>of</strong> new metabolites. Sample throughput: Since mass accuracy andresolution <strong>of</strong> TOF instruments are independent <strong>of</strong> the acquisition rate,they are perfectly suited for a coupling to UHPLC separations. Thesehyphenations enable a reduction <strong>of</strong> analysis time in combination witha high chromatographic resolution and therefore permit an increasedsample throughput. The UHR-TOF analysis revealed that an acquisitionrate <strong>of</strong> up to 20Hz did not compromise the achieved mass accuracy orresolution. Targeted and untargeted metabolite pr<strong>of</strong>iling: Acquisition <strong>of</strong>full scan accurate mass spectra enable the targeted screening for knowncompounds e.g. from the class <strong>of</strong> DKxanthenes based on very selectivehigh resolution EIC (hrEIC) traces with small mass windows <strong>of</strong> 1.0 - 0.5mDa. A comparison <strong>of</strong> several datasets following a “comprehensivefeature extraction” combined with a statistical analysis permits anuntargeted discovery <strong>of</strong> novel biomarkers using the same data filesas for the targeted analysis. Identification: Even a mass accuracy <strong>of</strong> 0.1ppm is not sufficient for an unambiguous formula identification for m/zvalues above 500. A combination <strong>of</strong> accurate mass data and isotopicpattern information in MS and MS/MS spectra can extend this m/z rangefor reliable formula suggestions. Examples for novel metabolites fromMyxobacteria will be shown.223 Metabolic Pr<strong>of</strong>iling <strong>of</strong> aCorynebacterium Glutamicum DeltaprpD2by GC-APCI High ResolutionQ-TOF AnalysisA. Barsch 1 , G. Zurek 1 , M. Persike 2 , J. Plassmeier 2 ,K. Niehaus 21Bruker Daltonik GmbH, Bremen, Germany;2Centrum für Biotechnologie, Universität Bielefeld,GermanyMetabolomics studies based on Gas chromatography -Massspectrometry (GC-MS) are well established and typically employelectron impact (EI) ionisation. Target compounds <strong>of</strong> interest canbe identified by comparison to commercial or public databases.Unfortunately, many possible biomarkers detected in metabolicpr<strong>of</strong>iling experiments cannot be identified due to the lack <strong>of</strong> referencespectra for a majority <strong>of</strong> biologically relevant compounds. Therefore,many possible biomarkers remain “unknowns” up till now. Hyphenatinggas chromatography with high resolution TOF-MS technology with s<strong>of</strong>tatmospheric pressure ionisation (APCI) can preserve the molecularion information and delivers accurate mass and isotopic patterninformation. This data enables a sum formula generation for knownand unknown target compounds.Additionally, optionally acquired MS/MS data can extend the capabilities for structural elucidation. Massaccuracy, resolution and isotopic fidelity are independent <strong>of</strong> the TOF-MS acquisition rate. Therefore, these instruments can be coupled to gaschromatography, which typically delivers narrow peak width requiringfast MS scan speeds. Corynebactrium glutamicum, a gram positive, nontoxicbacterium, is used in the industrial production <strong>of</strong> amino acids likelysine and glutamate. C. glutamicum can be grown on different carbonsources. Glucose is metabolised via glycolysis and the tricarboxylic acid(TCA) cycle, whereas propionate is catabolised through the methylcitricacid pathway. The prpD2 gene encodes a 2-methylcitrate dehydratasewhich is involved in the degradation <strong>of</strong> propionate. Metabolic pr<strong>of</strong>iling<strong>of</strong> Corynebacterium glutamicum delta-prpD2 extracts <strong>of</strong> cells grownon glucose or glucose and propionate analyzed by GC-APCI-TOF-MSrevealed several compounds elevated in cells grown on propionate.Identification <strong>of</strong> 2-methylcitric acid and alanine using accurate massand isotopic pattern information in MS and MS/MS spectra provided apro<strong>of</strong> <strong>of</strong> concept for the identification <strong>of</strong> target compounds using highresolution MS technology.224 Biomarker Discovery Using NewMetabolomics S<strong>of</strong>tware forAutomated Processing <strong>of</strong> HighResolution LC-MS DataD. Peake 1 , S. Hnatyshyn 2 ; M. Reily 2 ; P. Shipkova 2 ;T. McClure 1 ; M. Sanders 11Thermo Fisher Scientific, San Jose, CA, UnitedStates; 2 Bristol Myers Squibb, Princeton, NJ, UnitedStatesRobust biomarkers <strong>of</strong> target engagement and efficacy are required indifferent stages <strong>of</strong> drug discovery. Liquid chromatography coupledto high resolution mass spectrometry provides sensitivity, accuracyand wide dynamic range required for identification <strong>of</strong> endogenousmetabolites in biological matrices. LCMS is widely-used tool forbiomarker identification and validation. Typical high resolution LCMSpr<strong>of</strong>iles from biological samples may contain greater than a millionmass spectral peaks corresponding to several thousand endogenousmetabolites. Reduction <strong>of</strong> the total number <strong>of</strong> peaks, componentidentification and statistical comparison across sample groups remainsto be a difficult and time consuming challenge. Blood samples fromfourgroups <strong>of</strong> rats (male vs. female, fully satiated and food deprived)were analyzed using high resolution accurate mass (HRAM) LCMS.All samples were separated using a 15 minute reversed-phase C18LC gradient and analyzed in both positive and negative ion modes.Data was acquired using 15K resolution and 5ppm mass measurementaccuracy. The entire data set was analyzed using s<strong>of</strong>tware developedin collaboration between Bristol Meyers Squibb and Thermo FisherScientific to determine the metabolic effects <strong>of</strong> food deprivationon rats. Metabolomic LC-MS data files are extraordinarily complexand appropriate reduction <strong>of</strong> the number <strong>of</strong> spectral peaks viaidentification <strong>of</strong> related peaks and background removal is essential. Asingle component such as hippuric acid generates more than 20 relatedpeaks including isotopic clusters, adducts and dimers. Plasma andurine may contain 500-1500 unique quantifiable metabolites. Noisefiltering approaches including blank subtraction were used to reducethe number <strong>of</strong> irrelevant peaks. By grouping related signals such asisotopic peaks and alkali adducts, data processing was greatly simplifiedby reducing the total number <strong>of</strong> components by 10-fold. The s<strong>of</strong>twareprocesses 48 samples inunder 60minutes. Principle ComponentAnalysis showed substantial differences in endogenous metabolites94 • <strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine
levels between the animal groups. Annotation <strong>of</strong> components wasaccomplished via searching the ChemSpider database. Tentativeassignments made using accurate mass need further verification bycomparison with the retention time <strong>of</strong> authentic standards.225 On-Line Electrochemistry/MS - APowerful Tool for Rapid Prediction <strong>of</strong>Phase I and II Drug MetabolismJ. Powers 1 , J. Purkerson 1 , A. Kraj 2 , M. Eysberg 2 ,J.P. Chervet 21Antec, Palm Bay, FL, United States; 2 Antec,Zoeterwoude, The NetherlandsThe use <strong>of</strong> Electrochemsiry is a complementary approach to traditionalmethods such as in vivo (human, rodent) or in vitro (liver microsomes)metabolism studies, and delivers the oxidative metabolic fingerprint <strong>of</strong>a (drug) molecule in a very short time. The acquired mass spectra arepresented in simple 2 dimensional or more illustrative 3 dimensionalplots, so-called MS voltammograms. A MS voltammogram visualizesthe ion abundance versus m/z as a function <strong>of</strong> applied potential to theelectrochemical cell. With a MS voltammogram the optimal potentialcan be determined for electrochemical generation <strong>of</strong> the desiredmetabolite for further research, e.g., a phase II metabolism study (i.e.adduct formation). It is a quick method to identify reactive pathways<strong>of</strong> the compound <strong>of</strong> interest. Additionally, electrochemistry allows totrace the reactive metabolite conjugates with targets (e.g., proteins,glutathione) without matrix interactions in contrary to traditionalmethods. A dedicated s<strong>of</strong>tware program has been developed toautomate and simplify the MS voltammogram acquisition. The programcontrols the syringe pump, the potentiostat and triggers the acquisition<strong>of</strong> mass spectra at the designated cell potentials. The total acquisitiontime needed for recording <strong>of</strong> a full MS voltammogram can be as shortas 5 minutes. Amodiaquine an anti malaria agent was chosen as one <strong>of</strong>the model drugs to investigate oxidative metabolism using the on-lineEC/MS system with automated MS voltammogram acquisition The easyand fast Electrochemical conversion <strong>of</strong> Amodiaquine into its 4 majorphase I metabolites will be presented. In a second step Glutathione(GSH) is added to the electrochemically generated metabolites to formthe appropriate GSH-metabolite adducts, mimicking phase II reactions.All known adducts were successfully formed and identified with MS.Additionally, MS voltammograms <strong>of</strong> other drugs and xenobiotics (e.g.,acetaminophen, amiodarone, irinotecan) are presented. The datademonstrate that hyphenation <strong>of</strong> electrochemistry with electrospraymass spectrometry provides a versatile and user-friendly platformfor rapid and cost efficient screening <strong>of</strong> target compounds (drugs,xenobiotics, etc.) in phase I and phase II metabolomics studies.226 Facile Solid-Phase Synthesis <strong>of</strong>Peptide-p-Nitroanilide (pNA) AnalogContaining Conjugates Using a NovelWang or Rink Amide ResinX. Wang 1 , C. Po 2 , J. He 2 , A. Hong 21AnaSpec, Fremont, CA, United States; 2 EurogentecGroup, Fremont, CA, United StatesProteases play a key role in literally all biological processes, and are <strong>of</strong>great interest, especially to the pharmaceutical industry. Colorimetricbased Peptide-p-Nitroanilide conjugates (peptide-pNAs), withabsorbance at approximately 408 nm, have historically been and arestill widely used substrates for the study <strong>of</strong> protease activity. Thepreparation <strong>of</strong> peptide-pNA however, presents several technicalchallenges. Firstly, the amino group <strong>of</strong> pNA has a low nucleophilicproperty due to the electron-withdrawing effect <strong>of</strong> the nitro group.Secondly, the poor solubility <strong>of</strong> a p-nitroanilide intermediate and lastly,coupling in solution phase by DCC, azide or active ester, commonlyused techniques are not effective. Here we report the development<strong>of</strong> two novel supports for facile solid phase peptide syntheses,namely, Wang-resin and Rink Amide-resin conjugated with a pNAanalog, 5-amino-2-nitrobenzoic acid (Anb5,2). Based on a paper byHojo, et al. in which they described the introduction <strong>of</strong> Anb5,2 to ap-methylbenzhydrylamine (MB) resin; we successfully coupled Anb5,2to either Wang or Rink Amide resin using the TBTU method in thepresence <strong>of</strong> p-dimethylaminopyridine (DMAP). Anb5,2-Wang or RinkRmide resin is then coupled to a Fluorenylmethyloxycarbonyl (Fmoc)containing amino acid. Peptide synthesis can subsequently proceedusing Fmoc synthesis strategy. The use <strong>of</strong> this pNA analog containingresins circumvents the tehcnical difficulties stated above. These resinsalso greatly facilitates the synthesis <strong>of</strong> peptide-pNA-like chromogenicsubstrates for protease research.**227 Validation <strong>of</strong> an Ion MobilityHydrogen/Deuterium Exchange MassSpectrometry SystemK. Fadgen 2 , T. Wales 1 , M. Stapels 2 , M. Eggertson 1 ,J. Engen 21Northeastern University, Boston, MA, UnitedStates; 2 Waters Corporation, Milford, MA, UnitedStatesHydrogen/deuterium exchange mass spectrometry (HXMS) has provento be a useful analytical method for the study <strong>of</strong> protein dynamics andchanges to protein conformation. Rapid chromatographic separationsat 0°C must be utilized to preserve the deuterium label during LC/MS analysis. Unfortunately, fast, low temperature LC separations arenot very efficient and can cause spectral overlap for large proteins.The addition <strong>of</strong> a gas phase, ion mobility separation (IMS) into theHXMS workflow inserts an orthogonal separation that occurs on themillisecond timescale after the LC step without causing any detrimentalimpact on analysis <strong>of</strong> deuterium levels. An improved MS system hasrecently been developed that is capable <strong>of</strong> higher resolution gas-phasemobility separations. The improved MS platform was combined witha fully automated ultra performance liquid chromatography (UPLC)system developed for HXMS. To evaluate the effect <strong>of</strong> the new MSplatform on deuterium recovery, HXMS experiments were performedusing glycogen phosphorylase B as a model protein. Replicate studies<strong>of</strong> deuterium labeling reactions ranging from 10 seconds to 100minutes were evaluated. No significant deviation in deuterium levelswas observed when using either mobility (HDMSE) or non-mobility(MSE) separations and the standard deviation <strong>of</strong> deuterium uptakefor replicate analyses, for HDMSE and MSE separations were in goodagreement with one another. Using the newly developed protocol, anHXMS study <strong>of</strong> a monoclonal antibody was performed to comparedeuterium recovery using a 6 or 12 minute chromatographic separation.Even though chromatographic resolution was reduced with the fastergradient, HDMSE allowed several overlapping peptides to easily beinterrogated. In addition, the shorter analysis time improved deuteriumrecovery for the sample. The application <strong>of</strong> this additional level <strong>of</strong>separation will be essential in future studies <strong>of</strong> very large proteins inwhich chromatographic efficiency is expected to be suboptimal.Poster Abstracts<strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine • 95
- Page 7 and 8:
Meeting SponsorsThe Association of
- Page 9 and 10:
Registration ServicesRegistration S
- Page 12 and 13:
Presenter InformationPresenter Info
- Page 14 and 15:
AwardsABRF Annual Award for Outstan
- Page 16 and 17:
ABRF Robert A. Welch Outstanding Re
- Page 18 and 19:
Program-at-a-GlanceProgram-at-a-Gla
- Page 20 and 21:
Sunday, February 20 (Continued)(S1-
- Page 22 and 23:
Sunday, February 20 (Continued)(W3-
- Page 24 and 25:
Monday, February 21 (Continued)12:0
- Page 26 and 27:
Tuesday, February 22 (Continued)9:0
- Page 28 and 29:
Tuesday, February 22 (Continued)(W1
- Page 30 and 31:
Satellite Educational Workshop Spon
- Page 32 and 33:
SW2: An Introduction to Metabolomic
- Page 34 and 35:
SW4: Lean Management in Core Facili
- Page 36 and 37:
Plenary Session AbstractsPlenary Se
- Page 38 and 39:
Scientific Session AbstractsScienti
- Page 40 and 41:
Scientific SessionAbstractsstatisti
- Page 42 and 43:
Scientific SessionAbstracts(S5) Hig
- Page 44 and 45:
Scientific SessionAbstracts(S7-2) S
- Page 46 and 47: Workshop Session AbstractsWorkshop
- Page 48 and 49: Workshop SessionAbstractscase incor
- Page 50 and 51: Workshop SessionAbstracts(W7) Cellu
- Page 52 and 53: Workshop SessionAbstractsresolution
- Page 54 and 55: (W14-3) Galaxy Next Generation Sequ
- Page 56 and 57: Research Group Presentation Abstrac
- Page 58 and 59: Research GroupPresentation Abstract
- Page 60 and 61: Research GroupPresentation Abstract
- Page 62 and 63: Poster Session Abstracts**ABRF Post
- Page 64 and 65: Poster Abstractsglobal gene express
- Page 66 and 67: Poster Abstractsdiscussions of cont
- Page 68 and 69: Poster Abstractspossible applicatio
- Page 70 and 71: Poster Abstracts129 Bravo Automated
- Page 73 and 74: distribution. Additionally, we show
- Page 75 and 76: Illumina Genome Analyzer. PicoPlex
- Page 77 and 78: uniformity, reproducibility of enri
- Page 79 and 80: kits for Tempus TM and PAXgene® st
- Page 81 and 82: 165 Benchmarking miRNA ExpressionLe
- Page 83 and 84: Phoenix crystallography robot and a
- Page 85 and 86: Laboratory is located next door and
- Page 87 and 88: data of a Thermo Orbitrap instrumen
- Page 89 and 90: **197 Multi-Functional Superparamag
- Page 91 and 92: pattern of N-linked glycans in form
- Page 93 and 94: advantage of using two separate 15
- Page 95: allowed absolute quantitation. Comp
- Page 99 and 100: MuDPIT, and off-gel electrophoresis
- Page 101 and 102: 237 Multi-Site Assessment of Proteo
- Page 103 and 104: with good limits of quantification
- Page 105 and 106: 249 Rapid Monoclonal Antibody Glyca
- Page 107 and 108: OOng, J. - 117PPatel, S. - 169Peake
- Page 109 and 110: AnaSpec, Eurogentec Group Booth 417
- Page 111 and 112: FASEB MARC Program Booth 4169650 Ro
- Page 113 and 114: IntegenX, Inc. Booth 2015720 Stoner
- Page 115 and 116: Nonlinear Dynamics Booth 1052530 Me
- Page 117 and 118: Roche Applied Science Booth 5009115
- Page 119 and 120: Exhibit Hall FloorplanGrand Oaks Ba
- Page 121 and 122: Exhibitor List in Booth OrderExhibi
- Page 123 and 124: This workshop will present ways to
- Page 125 and 126: Grand Oaks Ballroom,Rooms P&Q, Leve
- Page 127 and 128: NotesNotesABRF 2011 — Technologie
- Page 129 and 130: Tuesday, February 22 — 12:00 pm -
- Page 131 and 132: MARCH 16-20, 2012 • DISNEY’S CO